Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Curr Opin Rheumatol. 2019 May;31(3):241–249. doi: 10.1097/BOR.0000000000000592

Figure 1: Screening and Monitoring Algorithm for ILD in Patients with SSc.

Figure 1:

* Lower limit of normal

** Clinically meaningful decline defined as FVC levels of >10% from baseline or decline in FVC ≥ 5% to < 10% and ≥ 15% relative decline in DLCO

@ Other causes of desaturation such as pulmonary hypertension should be ruled out

+ Based on Sircar et al., 201837

! Based on Khanna et al., 201639,53